Source: https://pixabay.com/en/code-programming-hacking-html-web-820275/
NDA for Soft Tissue Sarcoma Goes to the US FDA with Ample Evidence
The biopharmaceutical research and development company CytRx Corporation, announced an exciting new update early this month involving the company’s work with aldoxorubicin, a new drug for treatment in soft tissue sarcomas.…
Continue Reading
NDA for Soft Tissue Sarcoma Goes to the US FDA with Ample Evidence
